Milestones
2022
- Bora Biologics established and acquired Eden Biologics CDMO assets
- Bora acquired TWi Pharmaceuticals
2020
Acquire GSK’s Mississauga, Ontario (Canada) facility
2018
Acquired Impax Laboratories Inc. Taiwan Subsidiary and entered US CDMO market
2017
- Invested in Yuta Health to license CHC and OTC products of Eisai and SSP pharmaceutical in Taiwan
- Completed initial public offering at Taipei Exchange (GreTai Securities Market)
2014
- Bora Pharmaceuticals begins public trading on the GTSM ESB
- Acquired Union Chemicals Co., Ltd.
- Established official Research and Development Laboratory
2013
Acquired Tainan manufacturing site from Japanese Company
2007
Bora Pharmaceuticals established